Xponance, Inc. Cerus Corp Transaction History
Xponance, Inc.
- $10.2 Billion
- Q3 2024
A detailed history of Xponance, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Xponance, Inc. holds 11,234 shares of CERS stock, worth $17,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,234
Previous 11,460
1.97%
Holding current value
$17,749
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CERS
# of Institutions
155Shares Held
147MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$30.8 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$28.8 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$21.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$17.1 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$13.5 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $280M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...